Pharmacoepidemiology and Drug Safety

Article	Citations
	90
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer	73
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research	59
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018	50
Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus	46
Issue Information	45
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review	43
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data	42
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries	42
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using	41
Data Resource Profile: The Danish National Hospital Medicine Register	35
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	33
Letter to the Editor	32
Causal Forests Versus Inverse Probability of Treatment Weighting to Adjust for Cluster‐Level Confounding: A Parametric and Plasmode Simulation Study Based on US	31
External validity in distributed data networks	27
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm	27
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	27
ORAL PRESENTATION	25
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis	24
Development and Validation of an Endometrial Cancer Algorithm in US Claims Data	22
Issue Information	22
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review	21
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	21
Issue Information	20
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study	20

	20
Comorbidity influence in observational studies: Why ignore the real world?	20
Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study	19
	19
Issue Information	19
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions	19
Validity of ICD‐10‐based algorithms to identify patients with influenza in inpatient and outpatient settings	18
Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years	17
Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records	17
	17
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade	17
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe	16
Overlap Weights for Binary Outcomes: A Performance Assessment	16
The Challenges for Pharmacoepidemiologists Identifying Migraine in Electronic Healthcare Data Sources: A Systematic Literature Review	16
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology	16
Corrigendum to “A Brief Report on Proposed Areas of International Harmonization of Real‐World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators”	16
Assessment of a Modified High‐Dimensional Propensity Score Approach for UK Electronic Health Record Data: Evaluating Upper Gastrointestinal Safety of	15
Trends in the Dispensing of Oral Anti‐Cancer Medications Across Australia Over 10 Years	15
Identifying Extended‐Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data	15
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis	15
Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Regi	15
Medications for Nausea and Vomiting of Pregnancy and the Risks for Adverse Birth Outcomes	14
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases	14
Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium‐Glucose Cotransporter 2 Inhibitors	14
The Military Health System Data Repository: Leveraging Closed, Familial‐Linked Electronic Health Record Data for a Large Generalizable US Population	14
Issue Information	13
Hazard Ratios and Alternative Effect Measures: An Applied Illustration	13
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke	13
Probabilistic precision calculations for the planning of studies assessing negative binomial rates	13
An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer	13
Impact of Lookback Duration on the Performance of a Claims‐Based Frailty Proxy in Women With Stage I–III Breast Cancer	13
An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data	13
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis	13
Safety of BNT162b2 mRNA COVID ‐19 Vaccine Batches: A Nationwide Cohort Study	12
Hypertension medication from guidelines to practice: A cohort study in western Iran	12
Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–	12
Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation	12
Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review	12
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths	11
The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population	11
Federated analyses of multiple data sources in drug safety studies	11
Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community	11
Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management	11
Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real‐world data source on medication use in pregnancy in Belgium	11
Review of Mother–Infant Linkage Algorithms in Health Care Data Sources	11
Issue Information	11
Validation of alopecia coding in US claims data among women of childbearing age	11
Validation of an algorithm to identify fractures among patients within the Veterans Health Administration	11
Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids	11
Clozapine‐Associated Neutropenia Prevalence in a Large, Integrated Healthcare System	11

Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations	10
Characterization of SARS‐CoV‐2 Diagnostic Tests and Liver Function Tests Among Patients With COVID‐19 Diagnosed in Outpatient Settings Using Administrative Healthcare	10
Glucagon‐like Peptide‐1 Receptor Agonists in Asthma Exacerbations: An Application of High‐Dimensional Iterative Causal Forest to Identify Subgroups	10
Issue Information	10
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications	10
Issue Information	10
Valproic Acid‐Induced Congenital Disorders, an Analysis in EudraVigilance and a Literature Review of Valproic Acid Utilization During Pregnancy	10
Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus	10
10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology	10
Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries	9
Issue Information	9
	9
Consistency between the National Patient Register and the Swedish Cancer Register	9
Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe	9
Association of Quinolone Exposure in the First‐Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan	9
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies	9
ISPE20 Author Index	9
Issue Information	9
Effectiveness and Safety of Reduced and Standard Initial Doses of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study in Taiwan	9
Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database	9
Incidence and Clinical Significance of Drug‐Induced Antibodies and Hemolytic Anemia Associated With Beta‐Lactam Antibiotics: A Prospective Cohort Study	9
Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK : A Nested Case–Control and Case‐Cr	9
A drug utilization study of thiocolchicoside‐containing medicinal products for systemic use in France and Italy: A cross‐sectional electronic medical records database study	9
The risk of miscarriage after COVID‐19 vaccination before and during pregnancy	9
Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong	9
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned	9
A Cross‐Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real‐World Evidence	9
A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients	8
Dipeptidyl Peptidase‐4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease Requiring Dialysis	8
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System	8
Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan	8
Detecting and Dating Early Non‐live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries	8
Trends in clomiphene citrate and gonadotropins use in women with infertility between 2010 and 2017: A population‐based study in France	8
Validation Assessment of Privacy‐Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real‐World COVID‐19 Vaccine Effectiveness	8
ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24–28 August 2024	8
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE‐D) ISPE‐Endorsed Guidance	8
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data	7
Issue Information	7
Comparison of record linkage software for deduplicating patient identities in California's Prescription Drug Monitoring Program	7
	7
Issue Information	7
Assessing Research Impact With Bibliometrics and Altmetrics: The Case of the Canadian Network for Observational Drug Effect Studies ( CNODES )	7
Issue Information	7
	7
Signal detection of COVID‐19 vaccines adverse events using spontaneous reports from South Korea	7
TriNetX Dataworks‐ USA : Overview of a Multi‐Purpose, De‐Identified, Federated Electronic Health Record Real‐World Dat	7
Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes	7
Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta‐Analysis	7
	7
The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study	7
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in ty	7
Issue Information	7
Adverse drug reaction signal detection methods in spontaneous reporting system: A systematic review	7
Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan	6
Development and Validation of Claims‐Based Algorithms for Conjunctivitis and Keratitis	6
The Effect of Isoniazid for Tuberculosis Prevention on Pregnancy Risk Among Women Living With HIV on Antiretroviral Treatment and Progestin‐Based Hormonal Contraception	6
Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020	6
Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self‐Controlled Case Series Design	6
Prevalence of self‐medication practices among pregnant women in India: A systematic review and meta‐analysis	6
	6
Core Concepts: Self‐Controlled Designs in Pharmacoepidemiology	6
	6
Corrigendum	6
Real‐World Use of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistenc	6
Rescheduling gabapentinoids had negligible effects on prescribing behaviour by general practitioners in England	6
Preregistration: A Key to Credible Real‐World Evidence Generation	6
Issue Information	6
Mobile apps for quick adverse drug reaction report: A scoping review	6
Issue Information	6
Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees	6
Core Concepts in Pharmacoepidemiology: Principled Use of Artificial Intelligence and Machine Learning in Pharmacoepidemiology and Healthcare Research	6
Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study	6
Accuracy and validity of reported opioid prescription days' supply	6
Opioid tapering and mental health crisis in older adults	6
Patterns of filled prescriptions and the association with risk of drug‐induced death. A population‐based nested case‐control register study	6
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy	6
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual)	6
Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002–2025	6
Issue Information	5
Neonatal Outcome Ascertainment in Mother‐Infant Paired Claims	5

Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews	5
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis	5
Epidemiological Profile of Exogenous Intoxications by Self‐Medication in Brazil: A Decade of Trends and the Impact of the COVID ‐19	5
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs	5
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings	5
Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation	5
Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy	5
Current Use of Common Data Models in the Nordic Countries	5
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?	5
	5
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures	5
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses	5
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain	5
Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study	5
Validation studies of Japanese administrative health care data: A scoping review	5
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors	5
Overview of global real‐world data sources for pediatric pharmacoepidemiologic research	5
Antidepressant Use Trajectories and Risk of Discontinuation After Adolescents and Young Adult Cancer Diagnosis	5
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark	5
Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study	5
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022	5
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data	5
Real world prescription of beta‐blockers in patients with asthma	5
Issue Information	5
Comparing IPCW Models to Adjust for Informative Censoring During COVID ‐19 Using Data From the Cli	5
Correction to “A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data”	5
INSIGHT : A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety	5
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials	5
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis	5
Issue Information	5
Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT	5
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events	5
Impact and Effectiveness of COVID ‐19 mRNA Vaccination Against COVID	4
Identifying COVID ‐19 Disease Severity in Real‐World Data: Implications for Medical Product Effectiveness Studies	4
Development of a multivariate prediction model to identify individual case safety reports which require clinical review	4
Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014–2018)	4
Development and Application of an Algorithm for Statin‐Induced Myopathy Based on Electronic Health Record‐Derived Structured Elements	4
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies	4
Comparing Different As‐Treated Approaches: A Methodological Study Using Real‐World Data on Psorias	4
STUDENT ABSTRACTS of ISPE's 2024 Mid‐Year Meeting, Orlando, Florida, USA, 14–16 April 2024	4
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy	4
Stratified analysis in comparative effectiveness studies that emulate randomized trials	4
Issue Information	4
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching	4
Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims Data	4
Is it possible to identify risk factors for adverse drug reactions using a pharmacovigilance database based on spontaneous reporting?	4
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to	4
	4
High‐Throughput Screening Using the Self‐Controlled Tree‐Based Scan Statistic to Identify Medications Associated With Hospitalization for Severe Acute Liver Injury	4
Role of private prescriptions in the long‐term use of benzodiazepines and Z‐drugs: A patient‐related follow‐up study	4
Pain‐related hospitalization and emergency room visit following initial analgesic prescription after outpatient surgery	4
Prescriber Adherence to Antihypertensive Prescription Guidelines and the Impact of Patient Socioeconomic Factors: A Cross‐Sectional Study Using Data From the Irish Longitudinal Study on Ageing	4
Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ( ENCePP	4
	4
Diagnostic Performance of Prostate Cancer Disease‐Specific Phenotypes Identified Using Real‐World Databases: A Systematic Review	4
A Two‐Step Framework for Validating Causal Effect Estimates	4
Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure	4
Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy	4
Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users	4
Validation of an algorithm for identifying incident cancer cases based on long‐term illness and diagnosis related group program data from the French National Health Insurance Informati	4
Pain Medication and Pain Intensity Following Hip Fractures—Analyses Based on the ProFem Cohort Study	4
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program	4
	4
Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment	4
	4
Validity of claims data for identifying cancer incidence in the Japan public health center‐based prospective study for the next generation	4
Clarifying the causal contrast: An empirical example applying the prevalent new user study design	4
The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia	4
Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study	4
Evaluating the Impact of Data Standardization on Real‐World Data	4
Issue Information	4
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old	4
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data	4
Validation of ICD‐10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare System	4
Correction to “An Open‐Source Implementation of Tree‐Based Scan Statistics”	4
Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study	4
A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid	4
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy	4
Myopericarditis following COVID‐19 mRNA vaccination	4
Initiation of antidepressant medication in people with type 2 diabetes living in the United Kingdom—A retrospective cohort study	4
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach	3
	3
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV	3
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis	3
Risk of Hospitalized COVID ‐19 in COPD : Single‐Inhaler Triple Versus Dual Bronchodilator Therapy	3
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA‐2 trial	3
Curriculum in Pharmacoepidemiology Training Programs: A Cross‐Sectional Study to Assess Educational Needs and Alignment With Core Competencies	3
Design considerations for observational studies of drugs for advanced cancer	3
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe	3
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance	3
Comment on “Uncovering Medication Errors Leading to Hospital Admissions in the Emergency Department: An External, Prospective Validation of Clinical Decision Rules”	3
	3
Issue Information	3
An algorithm‐based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example	3
Vancomycin‐Induced Acute Kidney Injury in Intensive Care Patients: A Target Trial Emulation Study Using Multicenter Routinely Collected Data	3